{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:47:58Z","timestamp":1792813678897,"version":"4.5.0"},"reference-count":53,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union\u2019s Horizon Europe EIC Pathfinder","award":["101114924"],"award-info":[{"award-number":["101114924"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Cortisol excess in Cushing's disease (CD) induces widespread plasma protein alterations, affecting various pathways including coagulation and lipid metabolism. The extent to which these abnormalities normalize during long-term remission remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cohort study investigating plasma protein profiles in CD patients before, and during long-term remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>EDTA plasma samples of 26 CD patients were collected during active disease and during long-term remission (median 4.4 years, interquartile range 3.3-5.1). Plasma protein profiles were generated using quantitative protein mass spectrometry for 159 proteins, including 21 coagulation-related proteins, 18 complement proteins, 15 transport proteins, and 14 apolipoproteins. Protein levels before and after remission were compared with 80 controls (false discovery rate-adjusted t-test) with similar age and sex distribution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During active CD, 78 out of 159 proteins differed from controls, including 11 coagulation proteins, 10 transport proteins, and 3 apolipoproteins. Gelsolin and extracellular matrix protein-1 were most significantly changed. Following remission, 69 proteins changed significantly relative to active disease, but normalization was incomplete. Of the 78 proteins initially altered, 56 were similar to controls upon remission. After remission, 31 proteins remained different from controls, including coagulation proteins factor IX and factor XIII A chain, apolipoprotein A-II, several complement factors and extracellular matrix protein-1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Active CD is associated with profound alterations in plasma protein profiles across various functional domains. Long-term remission is accompanied by substantial, but incomplete normalization of plasma proteins. Sustained plasma protein abnormalities may contribute to persistent morbidities and ongoing adverse health risks after remission of CD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag120","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:53:35Z","timestamp":1777377215000},"page":"2774-2784","source":"Crossref","is-referenced-by-count":4,"title":["Distinct plasma protein profiles after long-term remission of Cushing's disease"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3568-8100","authenticated-orcid":false,"given":"Britte F","family":"van der Vliet","sequence":"first","affiliation":[{"name":"Department of Clinical Epidemiology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Camilleri","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ticiana","family":"Paes","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, University Medical Center Rotterdam , 3000 CA Rotterdam ,","place":["Netherlands"]},{"name":"Department of Internal Medicine, Roger Williams Medical Center , Providence, RI 02908 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Treep","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja","family":"Dolezal","sequence":"additional","affiliation":[{"name":"Department of Immunology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Cordfunke","sequence":"additional","affiliation":[{"name":"Department of Immunology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Wouter","family":"Drijfhout","sequence":"additional","affiliation":[{"name":"Department of Immunology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke R","family":"Biermasz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, and Center for Endocrine Tumors Leiden, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mettine H A","family":"Bos","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4707-2303","authenticated-orcid":false,"given":"Suzanne C","family":"Cannegieter","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["the Netherlands"]},{"name":"Department of Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits R","family":"Rosendaal","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"van Hylckama Vlieg","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf M","family":"Dekkers","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["the Netherlands"]},{"name":"Department of Medicine, Division of Endocrinology, and Center for Endocrine Tumors Leiden, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8394-6859","authenticated-orcid":false,"given":"Onno C","family":"Meijer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, and Center for Endocrine Tumors Leiden, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-9866","authenticated-orcid":false,"given":"Alberto M","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Amsterdam University Medical Center , 1105 AZ Amsterdam ,","place":["The Netherlands"]},{"name":"Amsterdam Gastroenterology Endocrinology and Metabolism , 1105 AZ Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo J","family":"Hofland","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, University Medical Center Rotterdam , 3000 CA Rotterdam ,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3737-3807","authenticated-orcid":false,"given":"L Renee","family":"Ruhaak","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-0754","authenticated-orcid":false,"given":"Frederikus A","family":"Klok","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J M","family":"van Vlijmen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-391X","authenticated-orcid":false,"given":"Richard A","family":"Feelders","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, University Medical Center Rotterdam , 3000 CA Rotterdam ,","place":["Netherlands"]},{"name":"Holman Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, NewYork University Langone Medical Center , New York, NY 10016 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"3","key":"2026091519585052300_dgag120-B1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing\u2019s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"9996","key":"2026091519585052300_dgag120-B2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"2026091519585052300_dgag120-B3","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s40618-022-01754-1","article-title":"Global Cushing\u2019s disease epidemiology: a systematic review and meta-analysis of observational studies","volume":"45","author":"Giuffrida","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2026091519585052300_dgag120-B4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-11-1095","article-title":"The burden of Cushing\u2019s disease: clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026091519585052300_dgag120-B5","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","article-title":"Hypercoagulable state in Cushing\u2019s syndrome: a systematic review","volume":"94","author":"Van Zaane","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026091519585052300_dgag120-B6","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with Cushing\u2019s syndrome: a multicenter cohort study","volume":"96","author":"Stuijver","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026091519585052300_dgag120-B7","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026091519585052300_dgag120-B8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-009-9186-y","article-title":"Hypercoagulability in Cushing\u2019s syndrome: the role of specific haemostatic and fibrinolytic markers","volume":"36","author":"Kastelan","year":"2009","journal-title":"Endocrine"},{"issue":"4","key":"2026091519585052300_dgag120-B9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1210\/jc.2011-2753","article-title":"The hypercoagulable state in Cushing\u2019s disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy","volume":"97","author":"van der Pas","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026091519585052300_dgag120-B10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.idc.2007.06.001","article-title":"Hypercortisolemia and infection","volume":"21","author":"Fareau","year":"2007","journal-title":"Infect Dis Clin North Am"},{"issue":"7","key":"2026091519585052300_dgag120-B11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2026091519585052300_dgag120-B12","doi-asserted-by":"crossref","first-page":"101667","DOI":"10.1016\/j.beem.2022.101667","article-title":"Effects of endocrine disorders on lipids and lipoproteins","volume":"37","author":"Newman","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"2026091519585052300_dgag120-B13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026091519585052300_dgag120-B14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12902-021-00679-9","article-title":"Outcomes of endoscopic transsphenoidal surgery for Cushing\u2019s disease","volume":"21","author":"Brady","year":"2021","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"2026091519585052300_dgag120-B15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/cen.14129","article-title":"Remission of hypertension after surgical cure of Cushing\u2019s syndrome","volume":"92","author":"Jha","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2026091519585052300_dgag120-B16","doi-asserted-by":"crossref","first-page":"e4490","DOI":"10.1210\/clinem\/dgaa625","article-title":"Persisting muscle dysfunction in Cushing\u2019s syndrome despite biochemical remission","volume":"105","author":"Vogel","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026091519585052300_dgag120-B17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12020-018-1664-7","article-title":"Lack of functional remission in Cushing\u2019s syndrome","volume":"61","author":"Vermalle","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"2026091519585052300_dgag120-B18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2265.2012.04479.x","article-title":"Hypercoagulable state in Cushing\u2019s syndrome is reversible following remission","volume":"78","author":"Kastelan","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026091519585052300_dgag120-B19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-10-0583","article-title":"Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing\u2019s syndrome: results from a prospective study before and after surgery","volume":"163","author":"Manetti","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026091519585052300_dgag120-B20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","article-title":"Metabolic and cardiovascular outcomes in patients with Cushing\u2019s syndrome of different aetiologies during active disease and 1 year after remission","volume":"75","author":"Giordano","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026091519585052300_dgag120-B21","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026091519585052300_dgag120-B22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11102-022-01218-y","article-title":"Glucocorticoid withdrawal syndrome following treatment of endogenous Cushing syndrome","volume":"25","author":"He","year":"2022","journal-title":"Pituitary"},{"issue":"3","key":"2026091519585052300_dgag120-B23","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1210\/clinem\/dgad453","article-title":"Long-term consequences of Cushing syndrome: a systematic literature review","volume":"109","author":"Puglisi","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026091519585052300_dgag120-B24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJMoa1613303","article-title":"Thromboprophylaxis after knee arthroscopy and lower-leg casting","volume":"376","author":"van Adrichem","year":"2017","journal-title":"N Engl J Med"},{"key":"2026091519585052300_dgag120-B25","doi-asserted-by":"crossref","unstructured":"Van der Vliet BF, Camilleri E, Paes T, et al \u00a0Supplemental material for: Distinct plasma protein profiles after long-term remission of Cushing\u2019s disease. Zenodo. 2026. 10.5281\/zenodo.19333401","DOI":"10.1210\/clinem\/dgag120"},{"issue":"3","key":"2026091519585052300_dgag120-B26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/jth.15623","article-title":"Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower-leg injury or knee arthroscopy","volume":"20","author":"Mohammed","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2026091519585052300_dgag120-B27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/bjh.70278","article-title":"Plasma proteomic profiles of patients during oral anti-coagulant treatment with vitamin K antagonists","volume":"208","author":"Camilleri","year":"2026","journal-title":"Br J Haematol"},{"issue":"6","key":"2026091519585052300_dgag120-B28","doi-asserted-by":"crossref","first-page":"103018","DOI":"10.1016\/j.rpth.2025.103018","article-title":"Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study","volume":"9","author":"Guman","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"6220","key":"2026091519585052300_dgag120-B29","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"609","key":"2026091519585052300_dgag120-B30","doi-asserted-by":"crossref","first-page":"eaaz0274","DOI":"10.1126\/scisignal.aaz0274","article-title":"The human secretome","volume":"12","author":"Uhl\u00e9n","year":"2019","journal-title":"Sci Signal"},{"issue":"1","key":"2026091519585052300_dgag120-B31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"3","key":"2026091519585052300_dgag120-B32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00357-014-9161-z","article-title":"Ward\u2019s hierarchical agglomerative clustering method: which algorithms implement Ward\u2019s criterion?","volume":"31","author":"Murtagh","year":"2014","journal-title":"J Classif"},{"key":"2026091519585052300_dgag120-B33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.thromres.2023.06.026","article-title":"Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: systematic review and meta-analysis","volume":"229","author":"Lowe","year":"2023","journal-title":"Thromb Res"},{"issue":"1-2","key":"2026091519585052300_dgag120-B34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cccn.2005.03.044","article-title":"Plasma free cortisol fraction reflects levels of functioning corticosteroid-binding globulin","volume":"359","author":"Lewis","year":"2005","journal-title":"Clin Chim Acta"},{"issue":"2","key":"2026091519585052300_dgag120-B35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0022-4731(87)90071-9","article-title":"Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin","volume":"26","author":"Coolens","year":"1987","journal-title":"J Steroid Biochem"},{"issue":"7","key":"2026091519585052300_dgag120-B36","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.metabol.2011.12.002","article-title":"A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease","volume":"61","author":"Kei","year":"2012","journal-title":"Metabolism"},{"issue":"23","key":"2026091519585052300_dgag120-B37","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1021\/bi300555d","article-title":"Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL","volume":"51","author":"Gao","year":"2012","journal-title":"Biochemistry"},{"issue":"3","key":"2026091519585052300_dgag120-B38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1172\/JCI112634","article-title":"Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation","volume":"78","author":"Lind","year":"1986","journal-title":"J Clin Invest"},{"issue":"9","key":"2026091519585052300_dgag120-B39","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/ijms19092516","article-title":"Plasma gelsolin: indicator of inflammation and its potential as a diagnostic tool and therapeutic target","volume":"19","author":"Piktel","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026091519585052300_dgag120-B40","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1038\/s41598-018-27265-9","article-title":"Serum proteomic profiling to identify biomarkers of premature carotid atherosclerosis","volume":"8","author":"Bhosale","year":"2018","journal-title":"Sci Rep"},{"key":"2026091519585052300_dgag120-B41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yjmcc.2023.03.012","article-title":"Role and therapeutic potential of gelsolin in atherosclerosis","volume":"178","author":"Zhang","year":"2023","journal-title":"J Mol Cell Cardiol"},{"issue":"17","key":"2026091519585052300_dgag120-B42","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.1016\/S0021-9258(18)68469-8","article-title":"Muscle is the major source of plasma gelsolin","volume":"263","author":"Kwiatkowski","year":"1988","journal-title":"J Biol Chem"},{"issue":"3","key":"2026091519585052300_dgag120-B43","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3803\/EnM.2021.1069","article-title":"Cushing syndrome associated myopathy: it is time for a change","volume":"36","author":"Reincke","year":"2021","journal-title":"Endocrinol Metab"},{"issue":"34","key":"2026091519585052300_dgag120-B44","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1073\/pnas.1801196115","article-title":"Extracellular matrix protein 1 promotes follicular helper T cell differentiation and antibody production","volume":"115","author":"He","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2026091519585052300_dgag120-B45","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.3390\/ijms22094788","article-title":"AP collagen peptides prevent cortisol-induced decrease of collagen type I in human dermal fibroblasts","volume":"22","author":"Chae","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026091519585052300_dgag120-B46","doi-asserted-by":"crossref","first-page":"738341","DOI":"10.3389\/fcell.2021.738341","article-title":"Glucocorticoids promote extracellular matrix component remodeling by activating YAP in human retinal capillary endothelial cells","volume":"9","author":"Gu","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2026091519585052300_dgag120-B47","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11427-024-2691-0","article-title":"Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis B","volume":"68","author":"Liu","year":"2025","journal-title":"Sci China Life Sci"},{"issue":"1","key":"2026091519585052300_dgag120-B48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12020-018-1819-6","article-title":"Factors predicting long-term comorbidities in patients with Cushing\u2019s syndrome in remission","volume":"64","author":"Schernthaner-Reiter","year":"2019","journal-title":"Endocrine"},{"issue":"2","key":"2026091519585052300_dgag120-B49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12020-016-0914-9","article-title":"The degree of urinary hypercortisolism is not correlated with the severity of Cushing\u2019s syndrome","volume":"55","author":"Guarnotta","year":"2017","journal-title":"Endocrine"},{"issue":"2","key":"2026091519585052300_dgag120-B50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.12259","article-title":"High variability in baseline urinary free cortisol values in patients with Cushing\u2019s disease","volume":"80","author":"Petersenn","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026091519585052300_dgag120-B51","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1213\/ANE.0000000000003511","article-title":"Repeated measures designs and analysis of longitudinal data: if at first you do not succeed-try, try again","volume":"127","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"issue":"7","key":"2026091519585052300_dgag120-B52","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s40618-025-02572-x","article-title":"Cardiometabolic complications after Cushing\u2019s disease remission","volume":"48","author":"Tizianel","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"2026091519585052300_dgag120-B53","doi-asserted-by":"crossref","first-page":"109090","DOI":"10.1016\/j.thromres.2024.109090","article-title":"Quantitative protein mass spectrometry for multiplex measurement of coagulation and fibrinolytic proteins towards clinical application: what, why and how?","volume":"241","author":"Camilleri","year":"2024","journal-title":"Thromb Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag120\/68197027\/dgag120.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/10\/2774\/68197027\/dgag120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/10\/2774\/68197027\/dgag120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:59:05Z","timestamp":1789516745000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/10\/2774\/8665919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,4,30]]},"published-print":{"date-parts":[[2026,9,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag120","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,4,30]]}}}